Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (131-140 of 389) with videos related to

Pageof 39
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 27, 2021
Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohortTrine Tramm, Hanne Vinter, Pernille Vahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 2, 2006
Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trialsHanne M Nielsen, Marie Overgaard, Cai Grau, et al.
International Journal of Radiation Biology|March 10, 2006
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serumSlavka Lukacova, Azza A Khalil, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|December 14, 2011
Tumourigenicity and radiation resistance of mesenchymal stem cellsFilippo P D'Andrea, Michael R Horsman, Moustapha Kassem, et al.
The Lancet. Oncology|October 4, 2005
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trialJens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2010
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitroBrita Singers Sørensen, Kasper Toustrup, Michael R Horsman, et al.
Acta Oncologica (Stockholm, Sweden)|September 2, 2016
Radiation-induced morbidity evaluated by high-frequency ultrasoundLine H Schack, Jan Alsner, Jens Overgaard, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?Birgitte V Offersen, Hans-Jürgen Brodersen, Mette M Nielsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 15, 2011
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neckKasper Toustrup, Brita Singers Sørensen, Pernille Lassen, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2020
Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancerKatrine Rye Hauerslev, Anders Husted Madsen, Jens Overgaard, et al.
Pageof 39

Showing results (131-140 of 389) with videos related to

Sort By:
Pageof 39
Acta Oncologica (Stockholm, Sweden)|October 27, 2021
Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohortTrine Tramm, Hanne Vinter, Pernille Vahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 2, 2006
Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trialsHanne M Nielsen, Marie Overgaard, Cai Grau, et al.
International Journal of Radiation Biology|March 10, 2006
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serumSlavka Lukacova, Azza A Khalil, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|December 14, 2011
Tumourigenicity and radiation resistance of mesenchymal stem cellsFilippo P D'Andrea, Michael R Horsman, Moustapha Kassem, et al.
The Lancet. Oncology|October 4, 2005
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trialJens Overgaard, Jesper Grau Eriksen, Marianne Nordsmark, et al.
Acta Oncologica (Stockholm, Sweden)|May 1, 2010
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitroBrita Singers Sørensen, Kasper Toustrup, Michael R Horsman, et al.
Acta Oncologica (Stockholm, Sweden)|September 2, 2016
Radiation-induced morbidity evaluated by high-frequency ultrasoundLine H Schack, Jan Alsner, Jens Overgaard, et al.
Breast Care (Basel, Switzerland)|May 24, 2012
Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?Birgitte V Offersen, Hans-Jürgen Brodersen, Mette M Nielsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 15, 2011
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neckKasper Toustrup, Brita Singers Sørensen, Pernille Lassen, et al.
Acta Oncologica (Stockholm, Sweden)|April 15, 2020
Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancerKatrine Rye Hauerslev, Anders Husted Madsen, Jens Overgaard, et al.
Pageof 39